NATURALLY-OCCURRING ESCAPE MUTANTS OF HEPATITIS-B VIRUS WITH VARIOUS MUTATIONS IN THE S-GENE IN CARRIERS SEROPOSITIVE FOR ANTIBODY TO HEPATITIS-B SURFACE-ANTIGEN
被引:272
作者:
YAMAMOTO, K
论文数: 0引用数: 0
h-index: 0
机构:JICHI MED SCH, DIV IMMUNOL, TOCHIGI 32904, JAPAN
YAMAMOTO, K
HORIKITA, M
论文数: 0引用数: 0
h-index: 0
机构:JICHI MED SCH, DIV IMMUNOL, TOCHIGI 32904, JAPAN
HORIKITA, M
TSUDA, F
论文数: 0引用数: 0
h-index: 0
机构:JICHI MED SCH, DIV IMMUNOL, TOCHIGI 32904, JAPAN
TSUDA, F
ITOH, K
论文数: 0引用数: 0
h-index: 0
机构:JICHI MED SCH, DIV IMMUNOL, TOCHIGI 32904, JAPAN
ITOH, K
AKAHANE, Y
论文数: 0引用数: 0
h-index: 0
机构:JICHI MED SCH, DIV IMMUNOL, TOCHIGI 32904, JAPAN
AKAHANE, Y
YOTSUMOTO, S
论文数: 0引用数: 0
h-index: 0
机构:JICHI MED SCH, DIV IMMUNOL, TOCHIGI 32904, JAPAN
YOTSUMOTO, S
OKAMOTO, H
论文数: 0引用数: 0
h-index: 0
机构:JICHI MED SCH, DIV IMMUNOL, TOCHIGI 32904, JAPAN
OKAMOTO, H
MIYAKAWA, Y
论文数: 0引用数: 0
h-index: 0
机构:JICHI MED SCH, DIV IMMUNOL, TOCHIGI 32904, JAPAN
MIYAKAWA, Y
MAYUMI, M
论文数: 0引用数: 0
h-index: 0
机构:JICHI MED SCH, DIV IMMUNOL, TOCHIGI 32904, JAPAN
MAYUMI, M
机构:
[1] JICHI MED SCH, DIV IMMUNOL, TOCHIGI 32904, JAPAN
[2] UNIV TOKUSHIMA, SCH MED, DEPT INTERNAL MED 2, TOKUSHIMA 770, JAPAN
[3] VIRAL HEPATITIS RES FDN JAPAN, TOKYO 113, JAPAN
[4] JAPANESE RED CROSS BLOOD CTR, YAMAGATA 753, JAPAN
[5] YAMANASHI MED COLL, DEPT INTERNAL MED 1, YAMANASHI 40938, JAPAN
Hepatitis B virus (HBV) DNA was extracted from sera of six carriers with hepatitis B e antigen as well as antibody to hepatitis B surface antigen and sequenced within the pre-S regions and the S gene. HBV DNA clones from five of these carriers had point mutations in the S gene, resulting in conversion from Ile-126 or Thr-126 of the wild-type virus to Ser-126 or Asn-126 in three carriers and conversion from Gly-145 to Arg-145 in three of them; clones with Asn-126 or Arg-145 were found in one carrier. All 12 clones from the other carrier had an insertion of 24 bp encoding an additional eight amino acids between Thr-123 and Cys-124. In addition, all or at least some of the HBV DNA clones from these carriers had in-phase deletions in the 5' terminus of the pre-S2 region. These results indicate that HBV escape mutants with mutations in the S gene affecting the expression of group-specific determinants would survive in some carriers after they seroconvert to antibody against surface antigen. Carriers with HBV escape mutants may transmit HBV either by donation of blood units without detectable surface antigen or through community-acquired infection, which would hardly be prevented by current hepatitis B immuneglobulin or vaccines.